These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 7340976

  • 21. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
    Sun A, Wang JT, Chia JS, Chiang CP.
    J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
    [Abstract] [Full Text] [Related]

  • 22. Levamisole therapy in nephrotic syndrome.
    Srivastava RN.
    Pediatr Nephrol; 1999 Sep; 13(7):636. PubMed ID: 10507834
    [No Abstract] [Full Text] [Related]

  • 23. Levamisole as an immunostimulant.
    Pár A.
    Ther Hung; 1980 Sep; 28(4):163-7. PubMed ID: 6782693
    [No Abstract] [Full Text] [Related]

  • 24. [Levamisole as an immunostimulant in primary lung cancer].
    Krzyśko R, Słowik-Gabryelska A.
    Pneumonol Pol; 1981 Jan; 49(1):29-34. PubMed ID: 7291005
    [No Abstract] [Full Text] [Related]

  • 25. Characterization of the immunostimulants levamisole and tetramisole.
    Spreafico F, Vecchi A, Mantovani A, Poggi A, Franchi G, Anaclerio A, Garattini S.
    Eur J Cancer (1965); 1975 Aug; 11(8):555-63. PubMed ID: 1222762
    [No Abstract] [Full Text] [Related]

  • 26. [Efficacy of some new Romanian drugs in treating herpetic keratitis].
    Popa DP, Stoica S, Iftimie M.
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1985 Aug; 29(1):39-43. PubMed ID: 3159050
    [No Abstract] [Full Text] [Related]

  • 27. [Immunomodulator (author's transl)].
    Mizushima Y.
    Ryumachi; 1980 Feb; 20(1):57-62. PubMed ID: 6966831
    [No Abstract] [Full Text] [Related]

  • 28. [Current indications for levamisole].
    Matkovics A.
    Orv Hetil; 2004 Oct 31; 145(44):2259-60. PubMed ID: 15626175
    [No Abstract] [Full Text] [Related]

  • 29. Immunocompetent cells and lymphocyte reactivity to mitogens in levamisole-treated brain tumor children.
    Hajnzić TF, Kastelan M, Lukac J, Hajnzić T.
    Pediatr Hematol Oncol; 1999 Oct 31; 16(4):335-40. PubMed ID: 10407870
    [Abstract] [Full Text] [Related]

  • 30. [Evaluation of immunostimulating agents used in pulmonologic practice].
    Kis'ova K, Zlatanov Z, Peneva M, Iankov K, Tsonev A.
    Vutr Boles; 1989 Oct 31; 28(3):85-90. PubMed ID: 2475980
    [Abstract] [Full Text] [Related]

  • 31. [Delayed hypersensitivity in patients with keratitis and results of its treatment with decaris].
    Orzeł H, Białek J, Krawczykowa Z, Denys A.
    Klin Oczna; 1982 Nov 31; 84(11):369-71. PubMed ID: 7183822
    [No Abstract] [Full Text] [Related]

  • 32. Effect of levamisole as an immunomodulating agent in trophoblastic lesions.
    Khanna A, Ojha KN, Gupta RM.
    Indian J Pathol Microbiol; 1993 Jan 31; 36(1):32-7. PubMed ID: 8354552
    [Abstract] [Full Text] [Related]

  • 33. [Results of combined anti-recurrence treatment of herpetic eye disease].
    Chaglakov IuA.
    Vestn Oftalmol; 1975 Jan 31; (6):28-32. PubMed ID: 1224473
    [No Abstract] [Full Text] [Related]

  • 34. [The characteristics of the pathogenesis and immunomodulator treatment in the postoperative period in pseudophakia patients].
    Boiştean V, Jeru I, Lupaşco V.
    Oftalmologia; 1996 Jan 31; 40(3):210-3. PubMed ID: 8962845
    [Abstract] [Full Text] [Related]

  • 35. Levamisole treatment in steroid sensitive nephrotic syndrome.
    Alshaya HO, Kari JA.
    Saudi Med J; 2002 Sep 31; 23(9):1101-4. PubMed ID: 12370722
    [Abstract] [Full Text] [Related]

  • 36. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)].
    Miyake M.
    Fukuoka Igaku Zasshi; 1981 Jun 31; 72(6):368-78. PubMed ID: 6975743
    [No Abstract] [Full Text] [Related]

  • 37. Levamisole: adjunctive therapy in steroid dependent minimal change nephrotic children.
    Donia AF, Amer GM, Ahmed HA, Gazareen SH, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Pediatr Nephrol; 2002 May 31; 17(5):355-8. PubMed ID: 12042893
    [Abstract] [Full Text] [Related]

  • 38. [Immunostimulation in chronic lymphocytic leukemia (author's transl)].
    Konopka L, Zywicka-Lopaciuk H, Sylwestrowicz T, Karpowicz M, Cieśluk S, Maślanka K, Pawelski S.
    Przegl Lek; 1981 May 31; 38(5):437-41. PubMed ID: 7268042
    [No Abstract] [Full Text] [Related]

  • 39. Levamisole: A multi-faceted drug in dermatology.
    Gupta M.
    Indian J Dermatol Venereol Leprol; 2016 May 31; 82(2):230-6. PubMed ID: 26924410
    [No Abstract] [Full Text] [Related]

  • 40. [Experience with the diagnostic and therapeutic use of herpetic polyvaccine].
    Kasparov AA, Maevskaia TM.
    Oftalmol Zh; 1972 May 31; 27(2):119-24. PubMed ID: 4337641
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.